{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,10]],"date-time":"2026-04-10T19:45:26Z","timestamp":1775850326739,"version":"3.50.1"},"reference-count":32,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2021,9,3]],"date-time":"2021-09-03T00:00:00Z","timestamp":1630627200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Immunol."],"abstract":"<jats:p>Autologous hematopoietic stem cell transplantation (aHSCT) represents an effective treatment for systemic sclerosis (SSc), but it also can cause immunological adverse events (iAEs). Therefore, we aimed to determine the frequency of iAEs [engraftment syndrome (ES) and secondary autoimmune disorder (sAD)] and to identify potential risk factors for their development in a retrospective analysis on 22 patients similarly transplanted due to SSc. While nine patients (41%) suffered from ESs, seven sADs occurred in six patients (27%). Patients who developed ES were older in our cohort (52.45 <jats:italic>vs.<\/jats:italic> 42.58 years, p = .0433, Cohen\u2019s d = 0.86), and cardiac involvement by SSc was associated with development of ES (OR = 40.11, p = .0017). Patients with manifestation of sAD had a higher modified Rodnan skin score (mRSS) reduction after aHSCT (90.50% <jats:italic>vs.<\/jats:italic> 60.00%, p = .0064, r = .65). Thus, IAEs are common after aHSCT for SSc and can occur in different stages during and after aHSCT with characteristic clinical manifestations. Good cutaneous response after aHSCT might be considered as a risk factor for sAD, and higher age at aHSCT and cardiac involvement might be considered as risk factors for the development of ES.<\/jats:p>","DOI":"10.3389\/fimmu.2021.723349","type":"journal-article","created":{"date-parts":[[2021,9,4]],"date-time":"2021-09-04T11:10:31Z","timestamp":1630753831000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":14,"title":["Immunological Adverse Events After Autologous Hematopoietic Stem Cell Transplantation in Systemic Sclerosis Patients"],"prefix":"10.3389","volume":"12","author":[{"given":"Patrick-Pascal","family":"Strunz","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Matthias","family":"Froehlich","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michael","family":"Gernert","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eva Christina","family":"Schwaneck","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anna","family":"Fleischer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ann-Christin","family":"Pecher","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hans-Peter","family":"Tony","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Joerg Christoph","family":"Henes","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marc","family":"Schmalzing","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1965","published-online":{"date-parts":[[2021,9,3]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2014.6368","article-title":"Autologous Hematopoietic Stem Cell Transplantation vs Intravenous Pulse Cyclophosphamide in Diffuse Cutaneous Systemic Sclerosis: A Randomized Clinical Trial","volume":"311","author":"van Laar","year":"2014","journal-title":"JAMA"},{"key":"B2","doi-asserted-by":"publisher","first-page":"498","DOI":"10.1016\/S0140-6736(11)60982-3","article-title":"Autologous Non-Myeloablative Haemopoietic Stem-Cell Transplantation Compared With Pulse Cyclophosphamide Once Per Month for Systemic Sclerosis (ASSIST): An Open-Label, Randomised Phase 2 Trial","volume":"378","author":"Burt","year":"2011","journal-title":"Lancet"},{"key":"B3","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1056\/nejmoa1703327","article-title":"Myeloablative Autologous Stem-Cell Transplantation for Severe Scleroderma","volume":"378","author":"Sullivan","year":"2018","journal-title":"N Engl J Med"},{"key":"B4","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2006-07-035766","article-title":"Development of a Secondary Autoimmune Disorder After Hematopoietic Stem Cell Transplantation for Autoimmune Diseases: Role of Conditioning Regimen Used","volume":"109","author":"Loh","year":"2007","journal-title":"Blood"},{"key":"B5","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2011-02-336156","article-title":"Secondary Autoimmune Diseases Occurring After HSCT for an Autoimmune Disease: A Retrospective Study of the EBMT Autoimmune Disease Working Party","volume":"118","author":"Daikeler","year":"2011","journal-title":"Blood"},{"key":"B6","first-page":"S","article-title":"ANCA-Positive Vasculitis as a Secondary Autoimmune Disease After Autologous Stem Cell Transplantation for Systemic Sclerosis: A Case Report","volume":"32","author":"Schmalzing","year":"2014","journal-title":"Clin Exp Rheumatol"},{"key":"B7","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2018.02390","article-title":"Autologous Hematopoietic Stem Cell Transplantation for Treatment of Systemic Sclerosis","volume":"9","author":"Del Papa","year":"2018","journal-title":"Front Immunol"},{"key":"B8","doi-asserted-by":"publisher","DOI":"10.3324\/haematol.2019.230128","article-title":"Autologous Stem Cell Transplantation for Progressive Systemic Sclerosis: A Prospective non-Interventional Study From the European Society for Blood and Marrow Transplantation Autoimmune Disease Working Party","volume":"106","author":"Henes","year":"2020","journal-title":"Haematologica"},{"key":"B9","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbmt.2015.08.030","article-title":"Engraftment Syndrome After Autologous Stem Cell Transplantation: An Update Unifying the Definition and Management Approach","volume":"21","author":"Cornell","year":"2015","journal-title":"Biol Blood Marrow Transpl"},{"key":"B10","doi-asserted-by":"publisher","DOI":"10.1038\/bmt.2014.296","article-title":"Engraftment Syndrome: Double-Edged Sword of Hematopoietic Cell Transplants","volume":"50","author":"Spitzer","year":"2015","journal-title":"Bone Marrow Transpl"},{"key":"B11","doi-asserted-by":"publisher","DOI":"10.1111\/ctr.13875","article-title":"Engraftment Syndrome Following Hematopoietic Stem Cell Transplant: A Review of the Literature","volume":"34","author":"Grant","year":"2020","journal-title":"Clin Transpl"},{"key":"B12","doi-asserted-by":"publisher","DOI":"10.1038\/sj.bmt.1703855","article-title":"Engraftment Syndrome Following Autologous Hematopoietic Stem Cell Transplantation: Definition of Diagnostic Criteria","volume":"31","author":"Maiolino","year":"2003","journal-title":"Bone Marrow Transpl"},{"key":"B13","doi-asserted-by":"publisher","DOI":"10.1038\/bmt.2009.363","article-title":"Engraftment Syndrome After Auto-SCT: Analysis of Diagnostic Criteria and Risk Factors in a Large Series From a Single Center","volume":"45","author":"Carreras","year":"2010","journal-title":"Bone Marrow Transpl"},{"key":"B14","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1037\/a0024338","article-title":"Effect Size Estimates: Current Use, Calculations, and Interpretation","volume":"141","author":"Fritz","year":"2012","journal-title":"J Exp Psychol Gen"},{"key":"B15","volume-title":"Statistical Power Analysis for the Behavioral Sciences","author":"Cohen","year":"1988"},{"key":"B16","article-title":"Engraftment Syndrome in Autologous Bone Marrow and Peripheral Stem Cell Transplantation","volume":"16","author":"Lee","year":"1995","journal-title":"Bone Marrow Transpl"},{"key":"B17","doi-asserted-by":"publisher","DOI":"10.1038\/sj.bmt.1703015","article-title":"Engraftment Syndrome Following Hematopoietic Stem Cell Transplantation","volume":"27","author":"Spitzer","year":"2001","journal-title":"Bone Marrow Transpl"},{"key":"B18","article-title":"CD34+ Selected Autologous Peripheral Blood Stem Cell Transplantation for Multiple Sclerosis: Report of Toxicity and Treatment Results at One Year of Follow-Up in 15 Patients","volume":"88","author":"Carreras","year":"2003","journal-title":"Haematologica"},{"key":"B19","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1016\/j.smim.2018.09.001","article-title":"NLRP3 Inflammasome Activation in Inflammaging","volume":"40","author":"Latz","year":"2018","journal-title":"Semin Immunol"},{"key":"B20","doi-asserted-by":"publisher","DOI":"10.1016\/j.cmet.2013.09.010","article-title":"Canonical NLRP3 Inflammasome Links Systemic Low-Grade Inflammation to Functional Decline in Aging","volume":"18","author":"Youm","year":"2013","journal-title":"Cell Metab"},{"key":"B21","article-title":"NLRP3-Inflammasomes are Triggered by Age-Related Hearing Loss in the Inner Ear of Mice","volume":"9","author":"Shi","year":"2017","journal-title":"Am J Transl Res"},{"key":"B22","doi-asserted-by":"publisher","first-page":"e37","DOI":"10.4110\/in.2019.19.e37","article-title":"Aging and the Immune System: The Impact of Immunosenescence on Viral Infection, Immunity and Vaccine Immunogenicity","volume":"19","author":"Oh","year":"2019","journal-title":"Immune Netw"},{"key":"B23","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1016\/j.clim.2018.04.002","article-title":"Immune Senescence, Epigenetics and Autoimmunity","volume":"196","author":"Ray","year":"2018","journal-title":"Clin Immunol"},{"key":"B24","doi-asserted-by":"publisher","DOI":"10.1038\/bmt.2015.299","article-title":"Does Ex Vivo CD34+ Positive Selection Influence Outcome After Autologous Hematopoietic Stem Cell Transplantation in Systemic Sclerosis Patients","volume":"51","author":"Oliveira","year":"2016","journal-title":"Bone Marrow Transplant"},{"key":"B25","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.0901773","article-title":"Regulatory T Cell (Treg) Subsets Return in Patients With Refractory Lupus Following Stem Cell Transplantation, and TGF-Beta-Producing CD8+ Treg Cells are Associated With Immunological Remission of Lupus","volume":"183","author":"Zhang","year":"2009","journal-title":"J Immunol"},{"key":"B26","doi-asserted-by":"publisher","DOI":"10.1093\/rheumatology\/keaa009","article-title":"Equal Rights in Autoimmunity: Is Sj\u00f6gren\u2019s Syndrome Ever \u2019Secondary\u2019","volume":"59","author":"Kollert","year":"2020","journal-title":"Rheumatol (Oxford)"},{"key":"B27","doi-asserted-by":"publisher","DOI":"10.1038\/pr.2011.57","article-title":"Complications of Autologous Hematopoietic Stem Cell Transplantation for Patients With Autoimmune Diseases","volume":"71","author":"Daikeler","year":"2012","journal-title":"Pediatr Res"},{"key":"B28","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMc076383","article-title":"Multiple Autoimmune Diseases After Autologous Stem-Cell Transplantation","volume":"357","author":"Bohgaki","year":"2007","journal-title":"N Engl J Med"},{"key":"B29","doi-asserted-by":"publisher","DOI":"10.1016\/s0092-8674(04)00335-6","article-title":"Homeostatic Expansion of T Cells During Immune Insufficiency Generates Autoimmunity","volume":"117","author":"King","year":"2004","journal-title":"Cell"},{"key":"B30","doi-asserted-by":"publisher","DOI":"10.1080\/08916930802197081","article-title":"Immune Re-Education Following Autologous Hematopoietic Stem Cell Transplantation","volume":"41","author":"Abrahamsson","year":"2008","journal-title":"Autoimmunity"},{"key":"B31","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2141.2003.04767.x","article-title":"Immune Reconstitution Following Haematopoietic Stem Cell Transplantation","volume":"124","author":"Peggs","year":"2004","journal-title":"Br J Haematol"},{"key":"B32","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbmt.2008.07.006","article-title":"Posttransplant Autoimmune Hemolytic Anemia and Other Autoimmune Cytopenias are Increased in Very Young Infants Undergoing Unrelated Donor Umbilical Cord Blood Transplantation","volume":"14","author":"Page","year":"2008","journal-title":"Biol Blood Marrow Transpl"}],"container-title":["Frontiers in Immunology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2021.723349\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,9,4]],"date-time":"2021-09-04T11:10:35Z","timestamp":1630753835000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2021.723349\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,9,3]]},"references-count":32,"alternative-id":["10.3389\/fimmu.2021.723349"],"URL":"https:\/\/doi.org\/10.3389\/fimmu.2021.723349","relation":{},"ISSN":["1664-3224"],"issn-type":[{"value":"1664-3224","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,9,3]]},"article-number":"723349"}}